Azurity Pharmaceuticals, Inc. v. Bionpharma Inc.

21-1926Court of Appeals for the Federal Circuit9 mars 2022

Texte intégral

NOTE: This disposition is nonprecedential.
United States Court of Appeals
for the Federal Circuit
______________________
AZURITY PHARMACEUTICALS, INC.,
Plaintiff-Appellant
v.
BIONPHARMA INC.,
Defendant-Appellee
______________________
2021-1926, 2021-1927
______________________
Appeals from the United States District Court for the
District of Delaware in Nos. 1:18-cv-01962-LPS, 1:19-
cv-01067-LPS, Judge Leonard P. Stark.
______________________
JUDGMENT
______________________
RICHARD TORCZON, Wilson, Sonsini, Goodrich & Rosati,
PC, Washington, DC, argued for plaintiff-appellant. Also
represented by TY WILLIAM CALLAHAN, GRANVILLE
CLAYTON KAUFMAN, Los Angeles, CA; WENDY L. DEVINE,
NICHOLAS SYLVESTER HALKOWSKI, KRISTINA M. HANSON,
San Francisco, CA; NATALIE J. MORGAN, San Diego, CA.
ANDREW M. ALUL, Taft, Stettinius & Hollister, LLP,
Chicago, IL, argued for defendant-appellee. Also repre-
sented by ROSHAN SHRESTHA.
Case: 21-1926 Document: 48 Page: 1 Filed: 03/09/2022

-- 1 of 2 --

______________________
T HIS CAUSE having been heard and considered, it is
O RDERED and ADJUDGED:
P ER CURIAM (N EWMAN, CLEVENGER , and STOLL , Cir-
cuit Judges).
AFFIRMED. See Fed. Cir. R. 36.
ENTERED BY O RDER OF THE COURT
March 9, 2022
Date
/s/ Peter R. Marksteiner
Peter R. Marksteiner
Clerk of Court
Case: 21-1926 Document: 48 Page: 2 Filed: 03/09/2022

-- 2 of 2 --

Poursuivez vos recherches dans ChatGPT ou Claude

Connectez Omnilex pour rechercher dans le corpus juridique depuis votre assistant IA.